• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORP. GEL-ONE; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORP. GEL-ONE; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number 0013D19G
Device Problem Insufficient Information (3190)
Patient Problems Itching Sensation (1943); Urticaria (2278)
Event Date 09/04/2013
Event Type  Injury  
Event Description
On (b)(6) 2013 - (b)(6) old male pt had an injection of gel-one in his knee for osteoarthritis.About six hours later, he developed diffuse itching, nausea, and flushing.In his words, "my whole body was a welt".He called the surgeon who prescribed a medrol dosepak and benadryl.This helped initially and he had relatively few symptoms on saturday and sunday, on (b)(6) 2013.On (b)(6) 2013 - he began to have increase in his rash again.On (b)(6) 2013 - on the day of admission, he was having intense diffuse itching again.This was not accompanied by as much as a rash.He saw the surgeon who sent him to the hospital as a direct admission.On (b)(6) 2013 - at the time of history and physical check, he was still having diffuse itching and was in an obvious state of some agitation because of benadryl he had been using.His vital signs were follows, temperature: 96, blood pressure: 114/74, pulse: 72, respirations: 18, body mass index: (b)(6).Heent examination results were unremarkable with minimal nasal congestion.Tonsils are absent.His respirations was normal.No wheezing.I/e ratio was normal.Speech was somewhat pressured, but he is not dysenteric with conversation or with moving about during the examination.S1 and s2 ecg were normal.Rhythm was regular with no murmurs.Peripheral pulse was good.He had notable for some blanching of the skin on light pressure suggestive of generalized erythroderma.There was no induration, and the skin was not particularly warm.It appeared salmon pink over some parts of his body such as the upper portion of the chest and portions of the arms and thighs.He had notable for generalized agitation.He spoke rapidly and was anxious.This did not appear to be due to physical distress as with pain, dyspnea, nausea.He was alert and oriented and furnishes details of the present illness well and quickly.No focal neurological deficits.Coordination was normal.No resting or action tremors.Strength was not tested in detail, but seems to be normal by observation.He was discharged.
 
Manufacturer Narrative
This is a definitive report.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GEL-ONE
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORP.
chiyoda-ku, tokyo 100- 0005
JA  100-0005
Manufacturer Contact
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0-005
52208556
MDR Report Key3565525
MDR Text Key4052479
Report Number9612392-2013-00007
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/06/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/09/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/18/2014
Device Lot Number0013D19G
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date09/30/2013
Device Age4 MO
Event Location Home
Date Report to Manufacturer12/05/2013
Date Manufacturer Received12/06/2013
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
COLCHICINE; NASACORT AQ; KETOCONAZOLE 2% TOPICAL CREAM; MULTIVITAMIN WITH MINERALS; GLUCOSAMINE; ASPIRIN; SIMVASTATIN; VIAGRA; MIRALAX; FLUOXETINE; GEMFIBROZIL; FISH OIL
Patient Outcome(s) Hospitalization;
Patient Age73 YR
Patient Weight94
-
-